Rejoice! The vaccine is nearly ready!
In case you didn’t see the big news this week, Pfizer has announced that the preliminary results from the “Phase 3, late-stage study” of their COVID-19 vaccine show that it is “more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis.”
Yay! As Dissembler-in-Chief Trump notes, this is a BIG WIN that was only made possible thanks to his COURAGEOUS LEADERSHIP in helping to WARP SPEED the wonderful vaccines directly into everyone’s veins (with the help of the US military, of course):
STOCK MARKET UP BIG, VACCINE COMING SOON. REPORT 90% EFFECTIVE. SUCH GREAT NEWS!
— Donald J. Trump (@realDonaldTrump) November 9, 2020
Oh yes, Mr. President, sir! SUCH GREAT NEWS!
. . . Except for just a couple of teensy-weensy little problems. Like the fact that this announcement is just that: an announcement. There is no data to scrutinize here, nothing presented for public review (let alone peer review). This is a press release—literal corporate PR and nothing more.
And the fact that, as even their own “trust us, it works” statement goes on to note (buried 310 words into this lesson in propaganda), “As the study continues, the final vaccine efficacy percentage may vary.” In other words: “We’re irresponsibly releasing preliminary results that don’t tell us anything because they make our future product look good and will generate a lot of excited media headlines in the mainstream corporate media that we fund with our advertising dollars.”
And there’s the fact that, right after the announcement (and subsequent media extravaganza), Pfizer’s CEO and executive vice president both sold millions of dollars worth of stock in the company. Nothing suspicious at all here, you crazy conspiracy theorists!
And then there’s the fact that the coronavirus vaccine trials themselves are a documented sham. As I discussed with James Evan Pilato on New World Next Week recently, the vaccine candidates are not even being measured on the basis of whether or not they can prevent infection, but whether they can reduce symptoms such as coughs and headaches in patients who have already tested positive. As even Forbes.com contributor Walter Hasseltine notes: “These trials seem designed to prove their vaccines work, even if the measured effects are minimal.”
But disregarding all of that, there’s one other major issue that has been glossed over in all the breathless coverage of this new miracle cure that is about to deliver us from the COVID plague: This “vaccine” is not a vaccine in the traditional sense. It is an experimental injectable technology that has never been used before in humans.
Learn more about Pfizer’s experimental vaccine in this week’s edition of The Corbett Report Subscriber.
To access the full newsletter and to support this website, please become a member today.
For free access to this editorial, please CLICK HERE.
This content is restricted to site members. If you are an existing user, please log in. New users may register below.